Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Datesort ascending Article Title Journal

Steven B.Cohen, Jennifer Unangst, Feng Yu

 November 2020 Enhancing the analytic utility of clinical trial data to inform health disparities research Contemporary Clinical Trials Communications

Khaled El Emam, Lucy Mosquera, Chaoyi Zheng

 November 2020 Optimizing the synthesis of clinical trial data using sequential trees Journal of the American Medical Informatics Association

CEO Roundtable on Cancer

 November 2020 Merck KGaA, Darmstadt, Germany, Recognized for Collaborative Cancer Research by CEO Roundtable on Cancer PR Newswire

Aurélie Lombard,  Hitesh Mistry,  Leon Aarons, Kayode Ogungbenro

 October 2020 Dose individualisation in oncology using chemotherapy‐induced neutropenia: Example of docetaxel in non‐small cell lung cancer patients British Journal of Clinical Pharmacology

Farees Saqlain, Sophia Z. Shalhout, Kevin S. Emerick, Tomas G. Neilan, Tatyana Sharova, David Michael Miller

 September 2020 Metastatic Merkel Cell Carcinoma Masquerading as Multiple Immune-Related Adverse Events Case Reports in Dermatological Medicine

Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller

 September 2020 Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Case Reports in Oncological Medicine

Sophia Z. Shalhout, Kevin S. Emerick, Peter M. Sadow, Jenny J. Linnoila, David M. Miller

 September 2020 Regionally Metastatic Merkel Cell Carcinoma Associated with Paraneoplastic Anti-N-methyl-D-aspartate Receptor Encephalitis Case Reports in Oncological Medicine

Hirotaka Miyashita, Christina Cruz, Cardinale Smith

 August 2020 Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate—a post hoc analysis of a randomized clinical trial Supportive Care in Cancer

Theresa Wizemann, Eeshan Khandekar, Jennifer Hinners, Carolyn Shore

 July 2020 Reflections on Sharing Clinical Trial Data: Challenges and a Way Forward: Proceedings of a Workshop (2020) National Academies Press

Omar Abdel-Rahman

 June 2020 Impact of Baseline Characteristics on Extensive-stage SCLC Patients Treated with Etoposide/Carboplatin; a Secondary Analysis of a Phase III Study The Clinical Respiratory Journal

G. Sonpavde, G. R. Pond, A. J. Templeton, E. D. Kwon, J.S. De Bono

 June 2020 Impact of single-agent daily prednisone on outcomes in men with metastatic castration-resistant prostate cancer Prostate Cancer and Prostatic Diseases

Hirotaka Miyashita, Christina Cruz, Stephen Malamud

 May 2020 Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate Breast Cancer Research and Treatment

Chun Pan, Bo Cai, Lianming Wang

 May 2020 A Bayesian approach for analyzing partly interval-censored data under the proportional hazards model Statistical Methods in Medical Research

Warit Ruanglertboon, Michael J. Sorich, Andrew Rowland, Ashley M. Hopkins 

 May 2020 Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients International Journal of Clinical Oncology

Pages